133 related articles for article (PubMed ID: 38513743)
1. Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment in a Population-Based Multinational Cohort Study.
Wiklund AK; Santoni G; Yan J; Radkiewicz C; Xie S; Birgisson H; Ness-Jensen E; von Euler-Chelpin M; Kauppila JH; Lagergren J
Gastroenterology; 2024 Mar; ():. PubMed ID: 38513743
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
[TBL] [Abstract][Full Text] [Related]
3. Cohort profile: Nordic Helicobacter Pylori eradication project (NordHePEP).
Pettersson AK; Santoni G; Yan J; Radkiewicz C; Xie S; Birgisson H; Ness-Jensen E; von Euler-Chelpin M; Kauppila JH; Lagergren J
Scand J Gastroenterol; 2023 May; 58(5):453-459. PubMed ID: 36369751
[TBL] [Abstract][Full Text] [Related]
4. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
[TBL] [Abstract][Full Text] [Related]
5.
Doorakkers E; Lagergren J; Engstrand L; Brusselaers N
Gut; 2018 Dec; 67(12):2092-2096. PubMed ID: 29382776
[TBL] [Abstract][Full Text] [Related]
6. [Eradication of Helicobacter pylori. Is it necessary to eradicate Helicobacter pylori in gastric reflux?].
de Korwin JD
Presse Med; 2001 Sep; 30(26):1313-20. PubMed ID: 11603095
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of
Guo CG; Zhang F; Jiang F; Wang L; Chen Y; Zhang W; Zhou A; Zhang S; Leung WK
Therap Adv Gastroenterol; 2023; 16():17562848231170943. PubMed ID: 37168403
[TBL] [Abstract][Full Text] [Related]
9. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study.
Yanes M; Santoni G; Maret-Ouda J; Ness-Jensen E; Färkkilä M; Lynge E; Nwaru B; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Eur J Cancer; 2020 Oct; 138():80-88. PubMed ID: 32877797
[TBL] [Abstract][Full Text] [Related]
10. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Leung WK; Wong IOL; Cheung KS; Yeung KF; Chan EW; Wong AYS; Chen L; Wong ICK; Graham DY
Gastroenterology; 2018 Jul; 155(1):67-75. PubMed ID: 29550592
[TBL] [Abstract][Full Text] [Related]
11. Decreased Risk of Esophageal Adenocarcinoma After Gastric Bypass Surgery in a Cohort Study From 3 Nordic Countries.
Hardvik Åkerström J; Santoni G; von Euler Chelpin M; Chidambaram S; Markar SR; Maret-Ouda J; Ness-Jensen E; Kauppila JH; Holmberg D; Lagergren J
Ann Surg; 2023 Dec; 278(6):904-909. PubMed ID: 37450697
[TBL] [Abstract][Full Text] [Related]
12. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
13. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
Li D; Jiang SF; Lei NY; Shah SC; Corley DA
Gastroenterology; 2023 Aug; 165(2):391-401.e2. PubMed ID: 37142201
[TBL] [Abstract][Full Text] [Related]
15. [Occurrence of upper gastrointestinal tract disease after Helicobacter pylori eradication].
Kodama M; Fujioka T; Murakami K; Sato R
Nihon Rinsho; 2001 Feb; 59(2):333-6. PubMed ID: 11218408
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.
Kumar S; Metz DC; Ellenberg S; Kaplan DE; Goldberg DS
Gastroenterology; 2020 Feb; 158(3):527-536.e7. PubMed ID: 31654635
[TBL] [Abstract][Full Text] [Related]
17. [Occurrence of upper gastrointestinal tract disease after Helicobacter pylori eradication].
Kodama M; Nomura N; Kagawa J; Fujioka T; Murakami K; Sato R
Nihon Rinsho; 2002 Aug; 60(8):1639-43. PubMed ID: 12187764
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication for the prevention of gastric neoplasia.
Ford AC; Yuan Y; Forman D; Hunt R; Moayyedi P
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD005583. PubMed ID: 32628791
[TBL] [Abstract][Full Text] [Related]
19. Incidence of esophageal carcinoma among Malays in North-Eastern Peninsular Malaysia: an area with an exceptionally low prevalence of Helicobacter pylori infection.
Lee YY; Raj SM; Sharif SE; Salleh R; Ayub MC; Graham DY
Dig Dis Sci; 2011 May; 56(5):1438-43. PubMed ID: 21082350
[TBL] [Abstract][Full Text] [Related]
20. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]